A method for in vitro culture of rat Zymbal gland: use in mechanistic studies of benzene carcinogenesis in combination with 32P-postlabeling.
Zymbal glands were excised bilaterally from the ear ducts of female Sprague-Dawley rats (three/group), minced into approximately four fragments per gland, and transferred into a microtiter plate containing 1.5 mL per well of Waymouth's tissue culture medium supplemented with fetal calf serum, hydrocortisone, insulin, and gentamicin. After addition of a test compound or solvent vehicle, plates were incubated for 6, 24, 48, or 96 hr at 37 degrees C in a humidified atmosphere of 5% CO2 in air. Tissue in culture for 6 hr was histologically indistinguishable from the freshly excised tissue, while that in culture for 24, 48, and 96 hr showed a progressive deterioration often with necrosis and/or squamous metaplasia. More pronounced deterioration was noted in samples treated with 750 or 1500 micrograms/mL of benzene. Using a nuclease P1-enhanced 32P-postlabeling assay, aromatic DNA adducts were detected in cultured Zymbal glands exposed for 48 hr to benzene and its derivatives, as well as to 7,12-dimethylbenzanthracene (DMBA) and 2-acetylaminofluorene (AAF). Benzene produced very low levels of adducts (0.5 adducts per 10(9) nucleotides), whereas its congeners produced relatively high levels of adducts (50-2000 lesions per 10(9) nucleotides), which decreased in the order benzoquinone greater than hydroquinone greater than phenol greater than benzenetriol greater than catechol. Each adduct profile overall was characteristic for the compound studied, suggesting the formation of compound-specific electrophiles. AAF and DMBA adducts were identical to those formed in vivo in animals. Our results show that the Zymbal glands are capable of metabolizing different carcinogens to DNA-reactive intermediates, a process that may be causally associated with tumor formation in vivo in this organ.
Reddy
M V
MV
Environmental and Health Science Laboratory, Mobil Oil Corporation, Princeton, NJ 08540.
Blackburn
G R
GR
Irwin
S E
SE
Kommineni
C
C
Mackerer
C R
CR
Mehlman
M A
MA
D015073:2-Acetylaminofluorene / Q000378:metabolism; D015127:9,10-Dimethyl-1,2-benzanthracene / Q000378:metabolism; D000818:Animals; D001554:Benzene / Q000378:metabolism*; D002273:Carcinogens / Q000378:metabolism*; D046508:Culture Techniques; D004247:DNA / Q000378:metabolism; D004424:Ear Canal / Q000378:metabolism* / Q000473:pathology; D005260:Female; D010761:Phosphorus Radioisotopes; D051381:Rats; D011919:Rats, Inbred Strains; D012627:Sebaceous Glands / Q000378:metabolism* / Q000473:pathology
D002273:Carcinogens; D010761:Phosphorus Radioisotopes; D015127:9,10-Dimethyl-1,2-benzanthracene; D004247:DNA; D015073:2-Acetylaminofluorene; D001554:Benzene